VAERS Explorer
Back to explore

Report #2878126

Received Dec 16, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Unknown
Age
21 yrs
State
IN
Recovered
Unknown
Vaccinated
Nov 24, 2024
Onset
Nov 24, 2025
Days to onset
365
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
HPV9HPV (GARDASIL 9)MERCK & CO. INC.UNK1957405—

Symptoms (2)

Expired product administeredNo adverse event

Symptom narrative

no side effects or symptoms were reported; patient received an expired dose of GARDASIL 9,; This spontaneous report was received from a medical student and refers to a 22-year-old patient of unknown gender. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On 24-Nov-2024, the patient received an expiry dose of Human Papillomavirus 9-valent Vaccine, Recombinant Injection (GARDASIL 9) (lot #1957405, expiration date: 11-Nov-2025) 0.5 mL for prophylaxis (Expired product administered). No side effects or symptoms were reported.